Biden doesn’t get it
By H. Holden Thorp,
Science
| 02. 18. 2022
It has been a rough 2 weeks for the US science community. After 4 years of bludgeoning by the Trump administration, hope resurged a year ago as a new White House promised to value science. But there have been missteps, the most recent taking place on the heels of another blunder that many saw coming. Eric Lander, who just stepped down as President Biden’s science adviser and director of the Office of Science and Technology Policy (OSTP), was a prominent research figure with a well-known record of bullying and callous actions. With the notable exception of the 500 Women Scientists organization, the scientific community was embarrassingly silent about Lander’s nomination. Not surprisingly, he is out of the White House because of the same behavioral issues. And yet, in another tone deaf move, the administration just named Francis Collins, the recently retired director of the National Institutes of Health (NIH), as Lander’s interim replacement as science adviser while asking Alondra Nelson, the OSTP’s deputy director for science and society and an experienced administrator and scholar, to temporarily direct OSTP. Apparently, Biden...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...